Severe lichenoid eruption due to concomitant medications following nivolumab administration

Severe lichenoid eruption due to concomitant medications following nivolumab administration

Abstract Recently, immune checkpoint inhibitors have been administered for several cancers and have shown great efficacy. However, they are associated with various immune‐related adverse events. Here, we report a case with severe lichenoid eruption following nivolumab administration that improved af...

Full description

Bibliographic Details
Main Authors: Risa Kakuta, Keiji Tanese, Kenro Hirata, Katsura Emoto, Sakiko Takeuchi, Chihiro Shiiya, Masayuki Amagai, Akiharu Kubo
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:JEADV Clinical Practice
Subjects:
immune checkpoint inhibitors
lichenoid eruption
nivolumab
PD‐1
PD‐L1
Online Access:https://doi.org/10.1002/jvc2.143

Internet

https://doi.org/10.1002/jvc2.143

Similar Items